Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
BRECHE: Sphenopalatine block vs blood patch for post-dural puncture syndrome
2025-522168-34-00Phase 2Authorised
- Sponsor
- Centre Hospitalier Universitaire de Clermont-Ferrand
- Start
- Nov 2025
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 2, randomised trial of lidocaine and prilocaine in post-dural puncture headache (PDPH) (2 arms), sponsored by Centre Hospitalier Universitaire de Clermont-Ferrand. Planned start Nov 2025; status: authorised.
02
Drugs
lidocaineprilocaine
03
Conditions
post-dural puncture headache (PDPH)
Beyond the preview
Go deeper on 2025-522168-34-00.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2025-522168-34-00.